These effects remain under active investigation in humans, and the evidence base is not yet definitive
Laboratory studies commonly explore receptor pharmacology, cyclic AMP signaling pathways, metabolic regulation, lipid metabolism, and cross-tissue endocrine communication
This page is presented for research and educational purposes only
O., Sun, B., Kuchar, J
Additional Resources Mercer: GLP-1 Considerations for 2026 Peterson-KFF: Employer Perspectives on GLP-1 Coverage Costs Blue Cross Blue Shield: How GLP-1s Could Increase Employer Premiums Morgan Lewis: GLP-1 Coverage, Obesity, and the ADA Related: ERISA Voluntary Benefits Compliance Checklist for Brokers (BenefitFlow) Sources for statistics cited in this article include SHRM, EBRI, HUB International, KFF, Mercer, Blue Cross Blue Shield Association, and the Business Group on Health
Linnebjerg H, Seger M, Kothare PA, Hunt T, Wolka AM, Mitchell MI